Live Breaking Biotech News and Articles

Biotech News Journal

Subscribe to Biotech News Journal: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Biotech News Journal: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


Latest News from Biotech News Journal
GLEN BURNIE, Md., Aug. 19, 2014 /PRNewswire/ -- CSSi, the leader in patient recruitment solutions for the clinical research industry, recently announced the formation of the company's Medical and Clinical Advisory Board ("MCAB") and is pleased to announce the addition of Dr. William E....
NEWPORT BEACH, Calif., Aug. 19, 2014 /PRNewswire/ -- Stradling Yocca Carlson & Rauth, P.C. ("Stradling") announced today that real estate attorney, James Richman, joins the Firm as Shareholder and Chair of its Real Estate practice group. Mr. Richman will be practicing out of its Sa...
ST. LOUIS, Aug. 19, 2014 /PRNewswire/ -- Sequence, Inc., an industry leader in the field of quality and compliance solutions for pharmaceutical, biotech and medical device manufacturers is opening a third office location in the "Gateway to the West," St. Louis, as a result of demand by...
JERUSALEM, August 19, 2014 /PRNewswire/ --
PALO ALTO, Calif., Aug. 19, 2014 /PRNewswire/ -- Cellular Research announced today the start of an early access program for its Precise™ assays and is currently making the product available to 10 sites.
Nutra Pharma Corp. (OTC: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), is announcing updates to the marketing plan for their over-the-counter (OTC) pain reliever, Nyloxin®. Nutra Pharma previously announce...
ROCKVILLE, Md., Aug. 19, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that its novel C. diffici...
Every year the Police Officers of Scottsdale Association (POSA) hosts a pair of events designed to bring joy and community connection to at-risk youths. Called the "Shop with a Cop" program, the project focuses on Back to School time and Christmas time, pairing up a kid with a cop who ...
CAMBRIDGE, Mass. and HERZLIYA-PITUACH, Israel, Aug. 19, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP"), a biotechnology company, today announced that it has received confirmation that its application to list its common sto...
JERUSALEM, August 19, 2014 /PRNewswire/ --
LONDON, Aug. 19, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
LONDON, Aug. 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
NEW YORK, Aug. 18, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
THOUSAND OAKS, Calif., Aug. 18, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that a second placebo-controlled Phase 3 study evaluating AMG 416 for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), receiving hemodialysis, me...
NEW YORK, Aug. 18, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
NEW YORK, Aug. 18, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
LOS ALTOS, Calif., Aug. 18, 2014 /PRNewswire/ -- Globavir Biosciences, Inc. ("Globavir"), a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outb...
NEW YORK, Aug. 18, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
DALLAS, Aug. 18, 2014 /PRNewswire-iReach/ -- This is a professional and in-depth market survey on Global and Chinese Cephalexin industry. The report firstly reviews the basic information of Cephalexin including its classification, application and manufacturing technology. The report th...
NEW YORK, Aug. 18, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
NEW YORK, Aug. 18, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
NEW YORK, August 18, 2014 /PRNewswire/ --
NEW YORK, August 18, 2014 /PRNewswire/ --
DALLAS, August 18, 2014 /PRNewswire/ --
DALLAS, August 18, 2014 /PRNewswire/ --
DALLAS, August 18, 2014 /PRNewswire/ --
DALLAS, August 18, 2014 /PRNewswire/ --
Investorideas.com (www.investorideas.com), a global news source covering leading sectors including sports stocks, releases the following recent interview with former world champion boxer in the lightweight and light middleweight classes, Vinny Pazienza (PAZ). Vinny discusses his upcomi...
ORLANDO, Fla., Aug. 18, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC-BB: TNIB) ("we" or the "Company") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, announced today that the Company is providing a ...
Research and Markets (http://www.researchandmarkets.com/research/65hvvs/healthcare) has announced the addition of the "Global Healthcare Analytics Market Report 2014 - Forecast to 2019" report to their offering.
Research and Markets (http://www.researchandmarkets.com/research/65hvvs/healthcare) has announced the addition of the "Global Healthcare Analytics Market Report 2014 - Forecast to 2019" report to their offering.
Research and Markets (http://www.researchandmarkets.com/research/65hvvs/healthcare) has announced the addition of the "Global Healthcare Analytics Market Report 2014 - Forecast to 2019" report to their offering.
NEW YORK, Aug. 18, 2014 /PRNewswire/ -- US-based Medtronic said it would purchase Ireland-based Covidien for $42.9 billion (press release: http://bit.ly/1qsbFqb), combining two of the world's biggest medical device makers and helping Medtronic savings with a headquarters change.  Kalor...
DALLAS, August 18, 2014 /PRNewswire/ --
DALLAS, August 18, 2014 /PRNewswire/ --
LONDON, August 18, 2014 /PRNewswire/ --
the most common form of lupus. The agreement also includes other, earlier stage compounds and an extensive library of assets positioned in the autoimmune disease space. The licensed assets are supported by an extensive portfolio of intellectual property consisting of over 45 worldwide ...
JUPITER, Fla., Aug. 18, 2014 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, bioph...